menu
    • menu
    [{"orgOrder":0,"company":"ScalmiBio","sponsor":"ALX Oncology","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Large molecule","year":"2021","type":"Acquisition","leadProduct":"Antibody","moa":"","graph1":"Oncology","graph2":"Undisclosed","graph3":"ScalmiBio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"ScalmiBio \/ ALX Oncology Holdings","highestDevelopmentStatusID":"1","companyTruncated":"ScalmiBio \/ ALX Oncology Holdings"}]

    Find Clinical Drug Pipeline Developments & Deals by ScalmiBio

    Menu

    ScalmiBio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            ScalmiBio

                            U.S.A arrow
                            Arena West Coast
                            Not Confirmed

                            ScalmiBio

                            U.S.A arrow
                            Arena West Coast
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Antibody

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : ALX Oncology

                            Deal Size : $4.5 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio

                            Details : ALX Oncology expands its pipeline with new anti-cancer drug candidates based on ScalmiBio’s platform and in combination with ALX Oncology’s lead candidate, evorpacept, a next-generation CD47 blocker designed to leverage the immune activation of broad...

                            Product Name : Undisclosed

                            Product Type : Large molecule

                            Upfront Cash : $6.5 million

                            October 07, 2021

                            Lead Product(s) : Antibody

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : ALX Oncology

                            Deal Size : $4.5 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth